wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38586543-705EBF3C-BCFF-4F1B-AC18-808EBB74562D
Q38586543-705EBF3C-BCFF-4F1B-AC18-808EBB74562D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38586543-705EBF3C-BCFF-4F1B-AC18-808EBB74562D
What is the status of novel anti-CD20 antibodies for chronic lymphocytic leukemia and are they set to leave rituximab in the shadows?
P2860
Q38586543-705EBF3C-BCFF-4F1B-AC18-808EBB74562D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38586543-705EBF3C-BCFF-4F1B-AC18-808EBB74562D
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
250af10d2ba9e886a6184774e6b991a79caf521a
P2860
Eradication of bone marrow minimal residual disease may prompt early treatment discontinuation in CLL.